BETA BIONICS INC

Historical 13F Holders

Symbol
BBNX
CUSIP
08659B102
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 08659B102 since 12/18/2024, largest first.

Filer % of Class Filed
Price T Rowe Associates Inc /MD/ 13G 16.6% 10/7/2026
Event 9/30/2026
Eventide Asset Management, LLC 13G/A
13.4% 5/15/2026
Event 3/31/2026
Zone Healthcare Holdings, LLC 13G/A
9.9% 11/12/2025
Event 9/30/2025
Soleus Capital Group, LLC 13G/A
9.8% 5/8/2026
Event 3/31/2026
Morgan Stanley 13G/A
8.6% 11/7/2025
Event 9/30/2025
Sands Capital Life Sciences Pulse Fund II, L.P. 13G/A
8.2% 8/13/2025
Event 6/30/2025
Farallon Capital Partners, L.P. 13G/A
8.1% 5/12/2026
Event 3/31/2026
Divisadero Street Capital Management, LP 13G
6.9% 7/24/2026
Event 7/17/2026
BlackRock, Inc. 13G 6.4% 10/17/2025
Event 9/30/2025
Soleus BB SPV, LLC 13G/A
5.8% 2/12/2026
Event 12/31/2025
Point72 Asset Management, L.P. 13G
5.2% 2/23/2026
Event 2/18/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
RTW Investments, LP 13G/A
4.5% 5/15/2026
Event 3/31/2026
Perceptive Advisors LLC 13G/A
3.7% 8/7/2025
Event 3/31/2025
Millennium Management LLC 13G/A
1.8% 10/16/2025
Event 9/30/2025
Farallon Capital Management, L.L.C. 13G/A
1.3% 8/13/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026
Wellington Management Group LLP 13G/A
0% 2/10/2026
Event 12/31/2025
Wellington Hadley Harbor Aggregator IV, L.P. 13G/A 0% 2/10/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 2.59 k $49.1 k
2026 Q2 138 48.0 M $753 M
2026 Q1 133 49.3 M $495 M
2025 Q4 161 47.2 M $1.44 B
2025 Q3 131 48.6 M $967 M
2025 Q2 118 44.9 M $659 M
2025 Q1 103 41.7 M $508 M